References
- Pharmaceutical Research and Manufacturers of America. Medicines in development for cancer 2015 report. Available online at: phrma.org/report/medicines-in-development-for-cancer-2015-report. Last accessed July 18, 2017.
- Weingart SN, Brown E, Bach PB. NCCN Task Force Report: Oral Chemotherapy. J Natl Cancer Ntwk. 2008;6(3):S1–S25.
- Ness S. Current oncology pipeline trends. Specialty Pharmacy Times. Available online at: pecialtypharmacytimes.com/publications/specialty-pharmacy-times/2013/may_june-2013/current-oncology-pipeline-trends. Last accessed July 18, 2017.
- Zafar SY, Abernethy AP. Financial toxicity, part I: A new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–81,149.
- Reff MJ, Peabody HB, Walters DR. Passionate financial support: An antidote for financial toxicity. Oncol Issues. 2015;30(3):62–64.
- Reff MJ. Physician dispensing adding value to the patient and the practice. Oncol Issues. 2014;3:38–43.
- Neuss M, Polovich M, McNiff K, Esper P, et al. 2013 Updated American Society of Clinical Oncologists/Oncology Nursing Society administration safety standards including standards for the safe administration and management of oral chemotherapy. Oncol Nurs Forum. 2013;40(3):225–233.